Global Cellular and Gene Therapy CDMO Market Growth (Status and Outlook) 2026-2032
The global Cellular and Gene Therapy CDMO market size is predicted to grow from US$ 3972 million in 2025 to US$ 6432 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
A Cellular and Gene Therapy CDMO is an organization that provides professional and customized R&D and manufacturing outsourcing services for the research and commercialization of cell and gene therapy drugs. The core of this service lies in covering the entire chain of process development and GMP production, from plasmids and viral vectors to cell drugs (CAR-T, stem cells, etc.). Its core value lies in helping innovative CGT (cell, gene, and drug development) companies overcome industrialization bottlenecks such as complex processes, high production costs, and stringent regulatory oversight, accelerating the process from preclinical research to IND (Investigational New Drug) application and commercialization. Services include process development (upstream cell culture and transfection, downstream purification), analytical method development, GMP-level production, stability studies, and application document preparation, making it an indispensable key support force in modern CGT drug development.
The global Cellular and Gene Therapy CDMO market is experiencing rapid growth driven by the explosion of CGT drug pipelines and surging demand for industrialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust regulatory frameworks, and extensive R&D pipelines to hold leading positions in AAV suspension processes, lentiviral GMP production, and plasmid CDMOs. The Asia-Pacific region has become the fastest-growing sector with the most rapid capacity expansion, and local CDMOs are quickly entering the global competitive arena. The industry as a whole is accelerating its evolution towards suspension process scale-up, gene editing integration, and automated closed-loop production.
LPI (LP Information)' newest research report, the “Cellular and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cellular and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cellular and Gene Therapy CDMO sales for 2026 through 2032. With Cellular and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cellular and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cellular and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cellular and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cellular and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cellular and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cellular and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cellular and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
A Cellular and Gene Therapy CDMO is an organization that provides professional and customized R&D and manufacturing outsourcing services for the research and commercialization of cell and gene therapy drugs. The core of this service lies in covering the entire chain of process development and GMP production, from plasmids and viral vectors to cell drugs (CAR-T, stem cells, etc.). Its core value lies in helping innovative CGT (cell, gene, and drug development) companies overcome industrialization bottlenecks such as complex processes, high production costs, and stringent regulatory oversight, accelerating the process from preclinical research to IND (Investigational New Drug) application and commercialization. Services include process development (upstream cell culture and transfection, downstream purification), analytical method development, GMP-level production, stability studies, and application document preparation, making it an indispensable key support force in modern CGT drug development.
The global Cellular and Gene Therapy CDMO market is experiencing rapid growth driven by the explosion of CGT drug pipelines and surging demand for industrialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust regulatory frameworks, and extensive R&D pipelines to hold leading positions in AAV suspension processes, lentiviral GMP production, and plasmid CDMOs. The Asia-Pacific region has become the fastest-growing sector with the most rapid capacity expansion, and local CDMOs are quickly entering the global competitive arena. The industry as a whole is accelerating its evolution towards suspension process scale-up, gene editing integration, and automated closed-loop production.
LPI (LP Information)' newest research report, the “Cellular and Gene Therapy CDMO Industry Forecast” looks at past sales and reviews total world Cellular and Gene Therapy CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Cellular and Gene Therapy CDMO sales for 2026 through 2032. With Cellular and Gene Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cellular and Gene Therapy CDMO industry.
This Insight Report provides a comprehensive analysis of the global Cellular and Gene Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cellular and Gene Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cellular and Gene Therapy CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cellular and Gene Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cellular and Gene Therapy CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Cellular and Gene Therapy CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell Therapy
- Viral Vectors
- Plasmid
- R&D-Grade CDMO
- Clinical-Grade CDMO
- Commercial-Scale CDMO
- Plasmid DNA CDMO
- Viral Vector CDMO
- Cell Therapy CDMO
- mRNA Drug CDMO
- Gene Editing Drug CDMO
- Others
- Commercial
- Academic Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- RoslinCT
- Thermo Scientific
- Andelyn Biosciences
- WuXi AppTec
- AGC Biologics
- Pfizer CentreOne
- Almac Group
- Samsung Biologics
- Ajinomoto Bio-Pharma Services
- Pharmaron
- OBiO
- Helixmith
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cellular and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cellular and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cellular and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cellular and Gene Therapy CDMO Segment by Type
2.2.1 Cell Therapy
2.2.2 Viral Vectors
2.2.3 Plasmid
2.2.4 Cellular and Gene Therapy CDMO Market Size by Type
2.2.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cellular and Gene Therapy CDMO Segment by Scale
2.3.1 R&D-Grade CDMO
2.3.2 Clinical-Grade CDMO
2.3.3 Commercial-Scale CDMO
2.3.4 Cellular and Gene Therapy CDMO Market Size by Scale
2.3.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032)
2.3.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
2.4 Cellular and Gene Therapy CDMO Segment by Technology
2.4.1 Plasmid DNA CDMO
2.4.2 Viral Vector CDMO
2.4.3 Cell Therapy CDMO
2.4.4 mRNA Drug CDMO
2.4.5 Gene Editing Drug CDMO
2.4.6 Others
2.4.7 Cellular and Gene Therapy CDMO Market Size by Technology
2.4.7.1 Cellular and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.7.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
2.5 Cellular and Gene Therapy CDMO Segment by Application
2.5.1 Commercial
2.5.2 Academic Research
2.5.3 Others
2.5.4 Cellular and Gene Therapy CDMO Market Size by Application
2.5.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELLULAR AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cellular and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cellular and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cellular and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY CDMO BY REGION
4.1 Cellular and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cellular and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cellular and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cellular and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cellular and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cellular and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELLULAR AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cellular and Gene Therapy CDMO Forecast
10.1.3 APAC Cellular and Gene Therapy CDMO Forecast
10.1.4 Europe Cellular and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cellular and Gene Therapy CDMO Forecast
10.2 Americas Cellular and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cellular and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cellular and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cellular and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cellular and Gene Therapy CDMO Forecast
10.3 APAC Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cellular and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cellular and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cellular and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cellular and Gene Therapy CDMO Forecast
10.3.5 India Market Cellular and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cellular and Gene Therapy CDMO Forecast
10.4 Europe Cellular and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cellular and Gene Therapy CDMO Forecast
10.4.2 France Market Cellular and Gene Therapy CDMO Forecast
10.4.3 UK Market Cellular and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cellular and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cellular and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cellular and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cellular and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cellular and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cellular and Gene Therapy CDMO Forecast
10.6 Global Cellular and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cellular and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cellular and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cellular and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cellular and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cellular and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cellular and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 Made Scientific
11.6.1 Made Scientific Company Information
11.6.2 Made Scientific Cellular and Gene Therapy CDMO Product Offered
11.6.3 Made Scientific Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Made Scientific Main Business Overview
11.6.5 Made Scientific Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cellular and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cellular and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Andelyn Biosciences
11.9.1 Andelyn Biosciences Company Information
11.9.2 Andelyn Biosciences Cellular and Gene Therapy CDMO Product Offered
11.9.3 Andelyn Biosciences Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Andelyn Biosciences Main Business Overview
11.9.5 Andelyn Biosciences Latest Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Information
11.10.2 WuXi AppTec Cellular and Gene Therapy CDMO Product Offered
11.10.3 WuXi AppTec Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi AppTec Main Business Overview
11.10.5 WuXi AppTec Latest Developments
11.11 AGC Biologics
11.11.1 AGC Biologics Company Information
11.11.2 AGC Biologics Cellular and Gene Therapy CDMO Product Offered
11.11.3 AGC Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AGC Biologics Main Business Overview
11.11.5 AGC Biologics Latest Developments
11.12 Pfizer CentreOne
11.12.1 Pfizer CentreOne Company Information
11.12.2 Pfizer CentreOne Cellular and Gene Therapy CDMO Product Offered
11.12.3 Pfizer CentreOne Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer CentreOne Main Business Overview
11.12.5 Pfizer CentreOne Latest Developments
11.13 Almac Group
11.13.1 Almac Group Company Information
11.13.2 Almac Group Cellular and Gene Therapy CDMO Product Offered
11.13.3 Almac Group Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Almac Group Main Business Overview
11.13.5 Almac Group Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Cellular and Gene Therapy CDMO Product Offered
11.14.3 Samsung Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Ajinomoto Bio-Pharma Services
11.15.1 Ajinomoto Bio-Pharma Services Company Information
11.15.2 Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Product Offered
11.15.3 Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Ajinomoto Bio-Pharma Services Main Business Overview
11.15.5 Ajinomoto Bio-Pharma Services Latest Developments
11.16 Pharmaron
11.16.1 Pharmaron Company Information
11.16.2 Pharmaron Cellular and Gene Therapy CDMO Product Offered
11.16.3 Pharmaron Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Pharmaron Main Business Overview
11.16.5 Pharmaron Latest Developments
11.17 OBiO
11.17.1 OBiO Company Information
11.17.2 OBiO Cellular and Gene Therapy CDMO Product Offered
11.17.3 OBiO Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 OBiO Main Business Overview
11.17.5 OBiO Latest Developments
11.18 Helixmith
11.18.1 Helixmith Company Information
11.18.2 Helixmith Cellular and Gene Therapy CDMO Product Offered
11.18.3 Helixmith Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Helixmith Main Business Overview
11.18.5 Helixmith Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cellular and Gene Therapy CDMO Market Size (2021-2032)
2.1.2 Cellular and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cellular and Gene Therapy CDMO by Country/Region (2021, 2025 & 2032)
2.2 Cellular and Gene Therapy CDMO Segment by Type
2.2.1 Cell Therapy
2.2.2 Viral Vectors
2.2.3 Plasmid
2.2.4 Cellular and Gene Therapy CDMO Market Size by Type
2.2.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
2.3 Cellular and Gene Therapy CDMO Segment by Scale
2.3.1 R&D-Grade CDMO
2.3.2 Clinical-Grade CDMO
2.3.3 Commercial-Scale CDMO
2.3.4 Cellular and Gene Therapy CDMO Market Size by Scale
2.3.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032)
2.3.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
2.4 Cellular and Gene Therapy CDMO Segment by Technology
2.4.1 Plasmid DNA CDMO
2.4.2 Viral Vector CDMO
2.4.3 Cell Therapy CDMO
2.4.4 mRNA Drug CDMO
2.4.5 Gene Editing Drug CDMO
2.4.6 Others
2.4.7 Cellular and Gene Therapy CDMO Market Size by Technology
2.4.7.1 Cellular and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.7.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
2.5 Cellular and Gene Therapy CDMO Segment by Application
2.5.1 Commercial
2.5.2 Academic Research
2.5.3 Others
2.5.4 Cellular and Gene Therapy CDMO Market Size by Application
2.5.4.1 Cellular and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
3 CELLULAR AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cellular and Gene Therapy CDMO Market Size Market Share by Player
3.1.1 Global Cellular and Gene Therapy CDMO Revenue by Player (2021-2026)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Cellular and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY CDMO BY REGION
4.1 Cellular and Gene Therapy CDMO Market Size by Region (2021-2026)
4.2 Global Cellular and Gene Therapy CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.4 APAC Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.5 Europe Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cellular and Gene Therapy CDMO Market Size by Country (2021-2026)
5.2 Americas Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
5.3 Americas Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cellular and Gene Therapy CDMO Market Size by Region (2021-2026)
6.2 APAC Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
6.3 APAC Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cellular and Gene Therapy CDMO Market Size by Country (2021-2026)
7.2 Europe Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cellular and Gene Therapy CDMO by Region (2021-2026)
8.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELLULAR AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.1 Global Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.1.2 Americas Cellular and Gene Therapy CDMO Forecast
10.1.3 APAC Cellular and Gene Therapy CDMO Forecast
10.1.4 Europe Cellular and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cellular and Gene Therapy CDMO Forecast
10.2 Americas Cellular and Gene Therapy CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Cellular and Gene Therapy CDMO Forecast
10.2.2 Canada Market Cellular and Gene Therapy CDMO Forecast
10.2.3 Mexico Market Cellular and Gene Therapy CDMO Forecast
10.2.4 Brazil Market Cellular and Gene Therapy CDMO Forecast
10.3 APAC Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.3.1 China Cellular and Gene Therapy CDMO Market Forecast
10.3.2 Japan Market Cellular and Gene Therapy CDMO Forecast
10.3.3 Korea Market Cellular and Gene Therapy CDMO Forecast
10.3.4 Southeast Asia Market Cellular and Gene Therapy CDMO Forecast
10.3.5 India Market Cellular and Gene Therapy CDMO Forecast
10.3.6 Australia Market Cellular and Gene Therapy CDMO Forecast
10.4 Europe Cellular and Gene Therapy CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Cellular and Gene Therapy CDMO Forecast
10.4.2 France Market Cellular and Gene Therapy CDMO Forecast
10.4.3 UK Market Cellular and Gene Therapy CDMO Forecast
10.4.4 Italy Market Cellular and Gene Therapy CDMO Forecast
10.4.5 Russia Market Cellular and Gene Therapy CDMO Forecast
10.5 Middle East & Africa Cellular and Gene Therapy CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Cellular and Gene Therapy CDMO Forecast
10.5.2 South Africa Market Cellular and Gene Therapy CDMO Forecast
10.5.3 Israel Market Cellular and Gene Therapy CDMO Forecast
10.5.4 Turkey Market Cellular and Gene Therapy CDMO Forecast
10.6 Global Cellular and Gene Therapy CDMO Forecast by Type (2027-2032)
10.7 Global Cellular and Gene Therapy CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cellular and Gene Therapy CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cellular and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cellular and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cellular and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cellular and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 Made Scientific
11.6.1 Made Scientific Company Information
11.6.2 Made Scientific Cellular and Gene Therapy CDMO Product Offered
11.6.3 Made Scientific Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Made Scientific Main Business Overview
11.6.5 Made Scientific Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cellular and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cellular and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Andelyn Biosciences
11.9.1 Andelyn Biosciences Company Information
11.9.2 Andelyn Biosciences Cellular and Gene Therapy CDMO Product Offered
11.9.3 Andelyn Biosciences Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Andelyn Biosciences Main Business Overview
11.9.5 Andelyn Biosciences Latest Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Information
11.10.2 WuXi AppTec Cellular and Gene Therapy CDMO Product Offered
11.10.3 WuXi AppTec Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 WuXi AppTec Main Business Overview
11.10.5 WuXi AppTec Latest Developments
11.11 AGC Biologics
11.11.1 AGC Biologics Company Information
11.11.2 AGC Biologics Cellular and Gene Therapy CDMO Product Offered
11.11.3 AGC Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AGC Biologics Main Business Overview
11.11.5 AGC Biologics Latest Developments
11.12 Pfizer CentreOne
11.12.1 Pfizer CentreOne Company Information
11.12.2 Pfizer CentreOne Cellular and Gene Therapy CDMO Product Offered
11.12.3 Pfizer CentreOne Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Pfizer CentreOne Main Business Overview
11.12.5 Pfizer CentreOne Latest Developments
11.13 Almac Group
11.13.1 Almac Group Company Information
11.13.2 Almac Group Cellular and Gene Therapy CDMO Product Offered
11.13.3 Almac Group Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Almac Group Main Business Overview
11.13.5 Almac Group Latest Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Cellular and Gene Therapy CDMO Product Offered
11.14.3 Samsung Biologics Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Samsung Biologics Main Business Overview
11.14.5 Samsung Biologics Latest Developments
11.15 Ajinomoto Bio-Pharma Services
11.15.1 Ajinomoto Bio-Pharma Services Company Information
11.15.2 Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Product Offered
11.15.3 Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Ajinomoto Bio-Pharma Services Main Business Overview
11.15.5 Ajinomoto Bio-Pharma Services Latest Developments
11.16 Pharmaron
11.16.1 Pharmaron Company Information
11.16.2 Pharmaron Cellular and Gene Therapy CDMO Product Offered
11.16.3 Pharmaron Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Pharmaron Main Business Overview
11.16.5 Pharmaron Latest Developments
11.17 OBiO
11.17.1 OBiO Company Information
11.17.2 OBiO Cellular and Gene Therapy CDMO Product Offered
11.17.3 OBiO Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 OBiO Main Business Overview
11.17.5 OBiO Latest Developments
11.18 Helixmith
11.18.1 Helixmith Company Information
11.18.2 Helixmith Cellular and Gene Therapy CDMO Product Offered
11.18.3 Helixmith Cellular and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Helixmith Main Business Overview
11.18.5 Helixmith Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cellular and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cellular and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Viral Vectors
Table 5. Major Players of Plasmid
Table 6. Cellular and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 9. Major Players of R&D-Grade CDMO
Table 10. Major Players of Clinical-Grade CDMO
Table 11. Major Players of Commercial-Scale CDMO
Table 12. Cellular and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Cellular and Gene Therapy CDMO Market Size by Scale (2021-2026) & ($ millions)
Table 14. Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
Table 15. Major Players of Plasmid DNA CDMO
Table 16. Major Players of Viral Vector CDMO
Table 17. Major Players of Cell Therapy CDMO
Table 18. Major Players of mRNA Drug CDMO
Table 19. Major Players of Gene Editing Drug CDMO
Table 20. Major Players of Others
Table 21. Cellular and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cellular and Gene Therapy CDMO Market Size by Technology (2021-2026) & ($ millions)
Table 23. Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
Table 24. Cellular and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. Global Cellular and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Cellular and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 29. Cellular and Gene Therapy CDMO Key Players Head office and Products Offered
Table 30. Cellular and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 35. Global Cellular and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Cellular and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Cellular and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 39. Americas Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 41. Americas Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 43. APAC Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 45. APAC Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Cellular and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 49. Europe Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Cellular and Gene Therapy CDMO
Table 55. Key Market Challenges & Risks of Cellular and Gene Therapy CDMO
Table 56. Key Industry Trends of Cellular and Gene Therapy CDMO
Table 57. Global Cellular and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Cellular and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Lonza Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 62. Lonza Cellular and Gene Therapy CDMO Product Offered
Table 63. Lonza Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Lonza Main Business
Table 65. Lonza Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 67. Charles River Laboratories Cellular and Gene Therapy CDMO Product Offered
Table 68. Charles River Laboratories Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Charles River Laboratories Main Business
Table 70. Charles River Laboratories Latest Developments
Table 71. Cytiva Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 72. Cytiva Cellular and Gene Therapy CDMO Product Offered
Table 73. Cytiva Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cytiva Main Business
Table 75. Cytiva Latest Developments
Table 76. Catalent Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 77. Catalent Biologics Cellular and Gene Therapy CDMO Product Offered
Table 78. Catalent Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Catalent Biologics Main Business
Table 80. Catalent Biologics Latest Developments
Table 81. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 82. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offered
Table 83. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. FUJIFILM Diosynth Biotechnologies Main Business
Table 85. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 86. Made Scientific Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 87. Made Scientific Cellular and Gene Therapy CDMO Product Offered
Table 88. Made Scientific Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Made Scientific Main Business
Table 90. Made Scientific Latest Developments
Table 91. RoslinCT Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 92. RoslinCT Cellular and Gene Therapy CDMO Product Offered
Table 93. RoslinCT Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. RoslinCT Main Business
Table 95. RoslinCT Latest Developments
Table 96. Thermo Scientific Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 97. Thermo Scientific Cellular and Gene Therapy CDMO Product Offered
Table 98. Thermo Scientific Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Thermo Scientific Main Business
Table 100. Thermo Scientific Latest Developments
Table 101. Andelyn Biosciences Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 102. Andelyn Biosciences Cellular and Gene Therapy CDMO Product Offered
Table 103. Andelyn Biosciences Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Andelyn Biosciences Main Business
Table 105. Andelyn Biosciences Latest Developments
Table 106. WuXi AppTec Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 107. WuXi AppTec Cellular and Gene Therapy CDMO Product Offered
Table 108. WuXi AppTec Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. WuXi AppTec Main Business
Table 110. WuXi AppTec Latest Developments
Table 111. AGC Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 112. AGC Biologics Cellular and Gene Therapy CDMO Product Offered
Table 113. AGC Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Biologics Main Business
Table 115. AGC Biologics Latest Developments
Table 116. Pfizer CentreOne Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 117. Pfizer CentreOne Cellular and Gene Therapy CDMO Product Offered
Table 118. Pfizer CentreOne Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Pfizer CentreOne Main Business
Table 120. Pfizer CentreOne Latest Developments
Table 121. Almac Group Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 122. Almac Group Cellular and Gene Therapy CDMO Product Offered
Table 123. Almac Group Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Almac Group Main Business
Table 125. Almac Group Latest Developments
Table 126. Samsung Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 127. Samsung Biologics Cellular and Gene Therapy CDMO Product Offered
Table 128. Samsung Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Samsung Biologics Main Business
Table 130. Samsung Biologics Latest Developments
Table 131. Ajinomoto Bio-Pharma Services Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 132. Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Product Offered
Table 133. Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Ajinomoto Bio-Pharma Services Main Business
Table 135. Ajinomoto Bio-Pharma Services Latest Developments
Table 136. Pharmaron Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 137. Pharmaron Cellular and Gene Therapy CDMO Product Offered
Table 138. Pharmaron Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Pharmaron Main Business
Table 140. Pharmaron Latest Developments
Table 141. OBiO Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 142. OBiO Cellular and Gene Therapy CDMO Product Offered
Table 143. OBiO Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. OBiO Main Business
Table 145. OBiO Latest Developments
Table 146. Helixmith Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 147. Helixmith Cellular and Gene Therapy CDMO Product Offered
Table 148. Helixmith Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Helixmith Main Business
Table 150. Helixmith Latest Developments
Table 1. Cellular and Gene Therapy CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cellular and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy
Table 4. Major Players of Viral Vectors
Table 5. Major Players of Plasmid
Table 6. Cellular and Gene Therapy CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 9. Major Players of R&D-Grade CDMO
Table 10. Major Players of Clinical-Grade CDMO
Table 11. Major Players of Commercial-Scale CDMO
Table 12. Cellular and Gene Therapy CDMO Market Size CAGR by Scale (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Cellular and Gene Therapy CDMO Market Size by Scale (2021-2026) & ($ millions)
Table 14. Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale (2021-2026)
Table 15. Major Players of Plasmid DNA CDMO
Table 16. Major Players of Viral Vector CDMO
Table 17. Major Players of Cell Therapy CDMO
Table 18. Major Players of mRNA Drug CDMO
Table 19. Major Players of Gene Editing Drug CDMO
Table 20. Major Players of Others
Table 21. Cellular and Gene Therapy CDMO Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Cellular and Gene Therapy CDMO Market Size by Technology (2021-2026) & ($ millions)
Table 23. Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology (2021-2026)
Table 24. Cellular and Gene Therapy CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 27. Global Cellular and Gene Therapy CDMO Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Cellular and Gene Therapy CDMO Revenue Market Share by Player (2021-2026)
Table 29. Cellular and Gene Therapy CDMO Key Players Head office and Products Offered
Table 30. Cellular and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 35. Global Cellular and Gene Therapy CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Cellular and Gene Therapy CDMO Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Cellular and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 39. Americas Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Table 41. Americas Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Table 43. APAC Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Table 45. APAC Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Cellular and Gene Therapy CDMO Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Country (2021-2026)
Table 49. Europe Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Cellular and Gene Therapy CDMO
Table 55. Key Market Challenges & Risks of Cellular and Gene Therapy CDMO
Table 56. Key Industry Trends of Cellular and Gene Therapy CDMO
Table 57. Global Cellular and Gene Therapy CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Cellular and Gene Therapy CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Lonza Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 62. Lonza Cellular and Gene Therapy CDMO Product Offered
Table 63. Lonza Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Lonza Main Business
Table 65. Lonza Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 67. Charles River Laboratories Cellular and Gene Therapy CDMO Product Offered
Table 68. Charles River Laboratories Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Charles River Laboratories Main Business
Table 70. Charles River Laboratories Latest Developments
Table 71. Cytiva Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 72. Cytiva Cellular and Gene Therapy CDMO Product Offered
Table 73. Cytiva Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Cytiva Main Business
Table 75. Cytiva Latest Developments
Table 76. Catalent Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 77. Catalent Biologics Cellular and Gene Therapy CDMO Product Offered
Table 78. Catalent Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Catalent Biologics Main Business
Table 80. Catalent Biologics Latest Developments
Table 81. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 82. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Offered
Table 83. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. FUJIFILM Diosynth Biotechnologies Main Business
Table 85. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 86. Made Scientific Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 87. Made Scientific Cellular and Gene Therapy CDMO Product Offered
Table 88. Made Scientific Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Made Scientific Main Business
Table 90. Made Scientific Latest Developments
Table 91. RoslinCT Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 92. RoslinCT Cellular and Gene Therapy CDMO Product Offered
Table 93. RoslinCT Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. RoslinCT Main Business
Table 95. RoslinCT Latest Developments
Table 96. Thermo Scientific Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 97. Thermo Scientific Cellular and Gene Therapy CDMO Product Offered
Table 98. Thermo Scientific Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Thermo Scientific Main Business
Table 100. Thermo Scientific Latest Developments
Table 101. Andelyn Biosciences Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 102. Andelyn Biosciences Cellular and Gene Therapy CDMO Product Offered
Table 103. Andelyn Biosciences Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Andelyn Biosciences Main Business
Table 105. Andelyn Biosciences Latest Developments
Table 106. WuXi AppTec Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 107. WuXi AppTec Cellular and Gene Therapy CDMO Product Offered
Table 108. WuXi AppTec Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. WuXi AppTec Main Business
Table 110. WuXi AppTec Latest Developments
Table 111. AGC Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 112. AGC Biologics Cellular and Gene Therapy CDMO Product Offered
Table 113. AGC Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. AGC Biologics Main Business
Table 115. AGC Biologics Latest Developments
Table 116. Pfizer CentreOne Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 117. Pfizer CentreOne Cellular and Gene Therapy CDMO Product Offered
Table 118. Pfizer CentreOne Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Pfizer CentreOne Main Business
Table 120. Pfizer CentreOne Latest Developments
Table 121. Almac Group Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 122. Almac Group Cellular and Gene Therapy CDMO Product Offered
Table 123. Almac Group Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Almac Group Main Business
Table 125. Almac Group Latest Developments
Table 126. Samsung Biologics Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 127. Samsung Biologics Cellular and Gene Therapy CDMO Product Offered
Table 128. Samsung Biologics Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Samsung Biologics Main Business
Table 130. Samsung Biologics Latest Developments
Table 131. Ajinomoto Bio-Pharma Services Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 132. Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Product Offered
Table 133. Ajinomoto Bio-Pharma Services Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Ajinomoto Bio-Pharma Services Main Business
Table 135. Ajinomoto Bio-Pharma Services Latest Developments
Table 136. Pharmaron Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 137. Pharmaron Cellular and Gene Therapy CDMO Product Offered
Table 138. Pharmaron Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Pharmaron Main Business
Table 140. Pharmaron Latest Developments
Table 141. OBiO Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 142. OBiO Cellular and Gene Therapy CDMO Product Offered
Table 143. OBiO Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. OBiO Main Business
Table 145. OBiO Latest Developments
Table 146. Helixmith Details, Company Type, Cellular and Gene Therapy CDMO Area Served and Its Competitors
Table 147. Helixmith Cellular and Gene Therapy CDMO Product Offered
Table 148. Helixmith Cellular and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Helixmith Main Business
Table 150. Helixmith Latest Developments
LIST OF FIGURES
Figure 1. Cellular and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cellular and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cellular and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cellular and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cellular and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cellular and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale in 2025
Figure 11. Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology in 2025
Figure 12. Cellular and Gene Therapy CDMO in Commercial
Figure 13. Global Cellular and Gene Therapy CDMO Market: Commercial (2021-2026) & ($ millions)
Figure 14. Cellular and Gene Therapy CDMO in Academic Research
Figure 15. Global Cellular and Gene Therapy CDMO Market: Academic Research (2021-2026) & ($ millions)
Figure 16. Cellular and Gene Therapy CDMO in Others
Figure 17. Global Cellular and Gene Therapy CDMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cellular and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 19. Global Cellular and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 20. Global Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cellular and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 26. United States Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 1. Cellular and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cellular and Gene Therapy CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cellular and Gene Therapy CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cellular and Gene Therapy CDMO Sales Market Share by Country/Region (2025)
Figure 8. Cellular and Gene Therapy CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cellular and Gene Therapy CDMO Market Size Market Share by Type in 2025
Figure 10. Global Cellular and Gene Therapy CDMO Market Size Market Share by Scale in 2025
Figure 11. Global Cellular and Gene Therapy CDMO Market Size Market Share by Technology in 2025
Figure 12. Cellular and Gene Therapy CDMO in Commercial
Figure 13. Global Cellular and Gene Therapy CDMO Market: Commercial (2021-2026) & ($ millions)
Figure 14. Cellular and Gene Therapy CDMO in Academic Research
Figure 15. Global Cellular and Gene Therapy CDMO Market: Academic Research (2021-2026) & ($ millions)
Figure 16. Cellular and Gene Therapy CDMO in Others
Figure 17. Global Cellular and Gene Therapy CDMO Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cellular and Gene Therapy CDMO Market Size Market Share by Application in 2025
Figure 19. Global Cellular and Gene Therapy CDMO Revenue Market Share by Player in 2025
Figure 20. Global Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 22. APAC Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 23. Europe Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cellular and Gene Therapy CDMO Market Size 2021-2026 ($ millions)
Figure 25. Americas Cellular and Gene Therapy CDMO Value Market Share by Country in 2025
Figure 26. United States Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Region in 2025
Figure 31. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 33. China Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Country in 2025
Figure 40. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cellular and Gene Therapy CDMO Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 56. APAC Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 57. Europe Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 59. United States Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 60. Canada Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 63. China Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 64. Japan Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 65. Korea Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 67. India Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 68. Australia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 69. Germany Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 70. France Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 71. UK Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 72. Italy Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 73. Russia Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 76. Israel Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
Figure 78. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cellular and Gene Therapy CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cellular and Gene Therapy CDMO Market Size 2027-2032 ($ millions)
